{
  "trial_id": "NCT03941730",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "History of locally advanced or metastatic breast cancer that is ERalpha negative or low (< 10% nuclear staining) and HER2 negative.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "=< 2 prior chemotherapy regimens for treatment of metastatic breast cancer.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Willing to submit a biopsy specimen from locally recurrent or metastatic site (or primary if metastatic site not available) of breast cancer for ERbeta staining to Mayo Clinic Anatomic Pathology.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Presence of moderate or strong nuclear ERbeta staining in > 25% of cells in specimen submitted during Pre-Screening Step.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Measurable or non-measurable disease as defined by Response Evaluation Criteria in Solid Tumors (RECIST) criteria.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "If history of brain metastases must meet the following criteria: Patients with a history of brain metastases are eligible only if they are asymptomatic and have stable disease for >= 3 months, including < 28 days of prior to pre-registration.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Not receiving steroids for brain metastases.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "ECOG performance status 0 or 1.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Prior treatment with paclitaxel and anthracycline (in combination or in separate regimens) either in the adjuvant or metastatic setting,",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "=< 2 prior chemotherapy regimens for treatment of metastatic breast cancer. (Note: Prior use of monoclonal antibodies targeting PD1, PDL1 is allowed.)",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Women must be postmenopausal.",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Uncontrolled intercurrent illness including, but not limited to: Ongoing or active infection.",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Symptomatic congestive heart failure.",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Unstable angina pectoris.",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Uncontrolled symptomatic cardiac arrhythmia.",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Uncontrolled hypertension (defined as blood pressure > 160/90).",
      "label": "triggers",
      "evidence": "none"
    }
  ],
  "notes": "",
  "_meta": {
    "topic_id": "61",
    "trial_id": "NCT03941730",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}